The Post Going Around
A genetics-and-wellness post breaks down how your DNA affects serotonin: the enzymes that make it, the gene that transports it, the receptors that receive it, and which variants are linked to psychiatric conditions. It's detailed, cites real studies, and is aimed at people who've done consumer DNA testing (23andMe, AncestryDNA) and want to know what their raw data means. Some of it holds up well. Some of it doesn't. And - important for this audience - most of it isn't actually about ADHD.
What's Solid
Serotonin synthesis: Serotonin (5-HT) is made from the amino acid tryptophan by an enzyme called tryptophan hydroxylase, encoded by two genes: TPH1, active mainly in the gut, skin, and pineal gland, and TPH2, which works specifically in the central nervous system. This is well-established, textbook-level biology.
Serotonin transport: The SLC6A4 gene encodes the serotonin transporter (SERT) - the protein SSRIs (selective serotonin reuptake inhibitors) target to keep more serotonin available between neurons. Also standard, uncontroversial science.
Serotonin syndrome: An excess of serotonin - usually from combining serotonergic drugs, such as an SSRI with an MAOI (monoamine oxidase inhibitor) - can cause a real and potentially dangerous reaction: restlessness, confusion, shivering, diarrhea, and in severe cases, death. This is accurate and worth knowing if you or someone you know takes multiple psychiatric or migraine medications.
Where the Claims Get Ahead of the Science
TPH2 and OCD: TPH2 gene variants do have real, replicated links to depression and bipolar disorder across multiple studies. The specific claim that TPH2 variants are linked to OCD is weaker - we could not find a solid, replicated body of evidence for that particular connection, as opposed to depression and bipolar disorder, which are better supported.
"HTR1 = passive coping, HTR2 = active coping": This tidy framing - that HTR1 receptors help you tolerate stress passively while HTR2 receptors help you actively cope and adapt - traces back to a single 2017 theoretical review by two researchers, who explicitly presented it as their own proposed model, not an established consensus. It's a genuinely interesting hypothesis. It is not settled science, and presenting it as fact overstates what we actually know.
The Part That Matters Most for This Audience: Serotonin Isn't ADHD's Core Biology
Here's the honest gap in most "genetics and serotonin" content aimed at a general audience: ADHD's primary neurobiology centers on dopamine and norepinephrine - the neurotransmitter systems involved in attention, motivation, and reward - not serotonin. Serotonin gene variants are far more directly tied to mood regulation, anxiety, and OCD-spectrum conditions than to the core attention and hyperactivity symptoms of ADHD itself.
That doesn't mean serotonin genetics is irrelevant to you if you have ADHD. It means the connection runs through comorbidity, not through ADHD's core mechanism:
- Anxiety and depression co-occur with ADHD at much higher rates than in the general population.
- Emotional dysregulation - intense, hard-to-regulate emotional reactions - is now recognized as a common feature of ADHD, even though it isn't in the official diagnostic criteria.
- Rejection sensitive dysphoria (RSD), an intense emotional response to perceived rejection or criticism reported by many people with ADHD, overlaps with the same mood-regulation circuitry serotonin genetics research focuses on.
So if serotonin genetics content resonates with you as someone with ADHD, it's likely resonating through these overlapping mood and emotional-regulation symptoms - not because it explains your attention difficulties.
The One Genuinely Useful, Verified Angle: Gut Bacteria and Depression Scores
A handful of real clinical trials have tested specific probiotic strains against depression symptoms, with results that held up to scrutiny:
- A randomized controlled trial of Lactobacillus rhamnosus HN001 (423 participants) found it reduced postpartum depression and anxiety symptoms.
- A clinical trial in IBS patients found Bifidobacterium longum reduced depression scores, though it didn't significantly change anxiety or IBS symptoms themselves.
- A trial combining Lactobacillus casei, Lactobacillus acidophilus, and Bifidobacterium bifidum found a significant decrease in depression scores compared to placebo in people with major depressive disorder.
This connects to the gut-brain axis research we've covered before - and it's a more evidence-backed, actionable thread than raw serotonin-gene interpretation, especially if anxiety or depression (rather than attention itself) is the symptom you're trying to address.
What's Actually Useful Here
- Don't treat consumer DNA "serotonin type" reports as a diagnosis for ADHD, depression, or anything else - they describe statistical associations from population studies, not individual predictions.
- If anxiety, depression, or emotional dysregulation are part of your picture alongside ADHD, that comorbidity - not raw serotonin genetics - is the more useful thing to discuss with a clinician.
- If you're on an SSRI, MAOI, or other serotonergic medication, know the signs of serotonin syndrome and always tell every prescriber about every medication and supplement you take.
- Specific, tested probiotic strains are a reasonable, low-risk thing to discuss with a doctor if depression symptoms are part of your picture - not as a replacement for treatment, but as a genuinely evidence-backed adjunct.
The Bigger Picture
Serotonin genetics is real science with real clinical relevance - just not primarily for ADHD's core symptoms. The honest version of this content connects serotonin genetics to what it actually explains well: mood regulation, depression, and OCD-spectrum conditions - which matter enormously for people with ADHD because of how often they co-occur, not because serotonin explains attention itself.
Sources: Walther et al., "Synthesis of serotonin by a second tryptophan hydroxylase isoform," Science (2003). Carhart-Harris & Nutt, "Serotonin and brain function: a tale of two receptors," Journal of Psychopharmacology (2017). Slykerman et al., PMC5652021. Pinto-Sanchez et al., PMID 28483500. Akkasheh et al., PMID 26706022.